| NYC Informatics™ |
| Angiotensin-Converting Enzyme Inhibitor (ACEI) and |
| Angiotensin II Receptor Blockers (ARBs) |
| Utilization Evaluation |
| Scripts by Class |
| Gender | DIUR | BETA | ACEI | ARBs | CCBs | BABs | MISC | UNKN |
| Female | 26 | 15 | 5,258 | 5,509 | 3 | 1 | . | 118 |
| Male | 21 | 25 | 7,087 | 5,251 | 11 | 8 | 1 | 137 |
| 47 | 40 | 12,345 | 10,760 | 14 | 9 | 1 | 255 |
| Two Scripts Combination by Class |
| Gender | ACEI DIUR |
ARBs DIUR |
BETA DIUR |
CCBs DIUR |
BABs DIUR |
DIUR MISC |
ACEI BETA |
ARBs BETA |
BETA CCBs |
BETA MISC |
| Female | 1,107 | 810 | 8 | 4 | 1 | 1 | 744 | 836 | 3 | . |
| Male | 1,036 | 494 | 1 | 4 | 5 | . | 1,429 | 782 | 11 | . |
| 2,143 | 1,304 | 9 | 8 | 6 | 1 | 2,173 | 1,618 | 14 | . |
| Three Scripts Combination by Class |
| Gender | ACEI BETA MISC |
ARBs BETA MISC |
BETA CCBs MISC |
ACEI BETA DIUR |
ARBs BETA DIUR |
BETA CCBs DIUR |
BABs CCBs DIUR |
ARBs BABs DIUR |
ACEI BABs DIUR |
| Female | 4 | 7 | . | 279 | 218 | 2 | 1 | 65 | 73 |
| Male | 3 | 4 | . | 327 | 182 | 2 | 1 | 52 | 141 |
| 7 | 11 | . | 606 | 400 | 4 | 2 | 117 | 214 |
| Four Scripts Combination by Class |
| Gender | BETA CCBs DIUR MISC |
ARBs BETA DIUR MISC |
ACEI BETA DIUR MISC |
BABs CCBs DIUR MISC |
ARBs BABs DIUR MISC |
ACEI BABs DIUR MISC |
| Female | . | 1 | 9 | . | 2 | 2 |
| Male | . | 2 | 5 | . | 1 | . |
| . | 3 | 14 | . | 3 | 2 |
| Data Source: Pharmacy, Managed Care and Traditional Claims |
| report generated on 23AUG2003 |
| www.nycinformatics.com |